• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

稳定性和活性降低的人类SIRT5变体不会在小鼠中引起神经病理学变化。

Human SIRT5 variants with reduced stability and activity do not cause neuropathology in mice.

作者信息

Yuan Taolin, Kumar Surinder, Skinner Mary E, Victor-Joseph Ryan, Abuaita Majd, Keijer Jaap, Zhang Jessica, Kunkel Thaddeus J, Liu Yanghan, Petrunak Elyse M, Saunders Thomas L, Lieberman Andrew P, Stuckey Jeanne A, Neamati Nouri, Al-Murshedi Fathiya, Alfadhel Majid, Spelbrink Johannes N, Rodenburg Richard, de Boer Vincent C J, Lombard David B

机构信息

Human and Animal Physiology, Wageningen University, De Elst 1, Wageningen, the Netherlands.

Department of Pathology & Laboratory Medicine, Miller School of Medicine, and Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL 33136, USA.

出版信息

iScience. 2024 May 15;27(6):109991. doi: 10.1016/j.isci.2024.109991. eCollection 2024 Jun 21.

DOI:10.1016/j.isci.2024.109991
PMID:38846003
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC11154205/
Abstract

SIRT5 is a sirtuin deacylase that removes negatively charged lysine modifications, in the mitochondrial matrix and elsewhere in the cell. In benign cells and mouse models, under basal conditions, the phenotypes of SIRT5 deficiency are quite subtle. Here, we identify two homozygous variants in patients suspected to have mitochondrial disease. Both variants, P114T and L128V, are associated with reduced SIRT5 protein stability and impaired biochemical activity, with no evidence of neomorphic or dominant negative properties. The crystal structure of the P114T enzyme was solved and shows only subtle deviations from wild-type. Via CRISPR-Cas9, we generated a mouse model that recapitulates the human P114T mutation; homozygotes show reduced SIRT5 levels and activity, but no obvious metabolic abnormalities, neuropathology, or other gross phenotypes. We conclude that these human variants most likely represent severe hypomorphs, but are likely not by themselves the primary pathogenic cause of the neuropathology observed in the patients.

摘要

SIRT5是一种去乙酰化酶,可去除线粒体基质和细胞其他部位带负电荷的赖氨酸修饰。在良性细胞和小鼠模型中,在基础条件下,SIRT5缺乏的表型相当微妙。在此,我们在疑似患有线粒体疾病的患者中鉴定出两个纯合变体。这两个变体,P114T和L128V,均与SIRT5蛋白稳定性降低和生化活性受损有关,没有新功能或显性负性特性的证据。解析了P114T酶的晶体结构,结果显示其与野生型仅有细微偏差。通过CRISPR-Cas9,我们构建了一个重现人类P114T突变的小鼠模型;纯合子显示SIRT5水平和活性降低,但没有明显的代谢异常、神经病理学或其他明显表型。我们得出结论,这些人类变体很可能代表严重的亚效等位基因,但它们本身可能不是患者中观察到的神经病理学的主要致病原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11154205/efb666a34cd3/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11154205/e0b62ab9fc35/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11154205/316d51235183/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11154205/ba5c09413e0c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11154205/19c66a419c37/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11154205/ed951aa22bc2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11154205/6b1a92b21972/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11154205/b4b247828b19/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11154205/efb666a34cd3/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11154205/e0b62ab9fc35/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11154205/316d51235183/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11154205/ba5c09413e0c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11154205/19c66a419c37/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11154205/ed951aa22bc2/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11154205/6b1a92b21972/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11154205/b4b247828b19/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea4a/11154205/efb666a34cd3/gr7.jpg

相似文献

1
Human SIRT5 variants with reduced stability and activity do not cause neuropathology in mice.稳定性和活性降低的人类SIRT5变体不会在小鼠中引起神经病理学变化。
iScience. 2024 May 15;27(6):109991. doi: 10.1016/j.isci.2024.109991. eCollection 2024 Jun 21.
2
variants from patients with mitochondrial disease are associated with reduced SIRT5 stability and activity, but not with neuropathology.线粒体疾病患者的变异与SIRT5稳定性和活性降低有关,但与神经病理学无关。
bioRxiv. 2023 Dec 8:2023.12.06.570371. doi: 10.1101/2023.12.06.570371.
3
Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology.SIRT5 去乙酰化酶在正常生理学和病理生物学中的功能。
Crit Rev Biochem Mol Biol. 2018 Jun;53(3):311-334. doi: 10.1080/10409238.2018.1458071. Epub 2018 Apr 11.
4
SIRT5 deacylates metabolism-related proteins and attenuates hepatic steatosis in ob/ob mice.SIRT5 去酰化代谢相关蛋白,减轻 ob/ob 小鼠的肝脂肪变性。
EBioMedicine. 2018 Oct;36:347-357. doi: 10.1016/j.ebiom.2018.09.037. Epub 2018 Sep 29.
5
Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5.蛋白赖氨酸去乙酰化酶 Sirtuin 5 的治疗潜力和活性调节。
J Med Chem. 2022 Jul 28;65(14):9580-9606. doi: 10.1021/acs.jmedchem.2c00687. Epub 2022 Jul 8.
6
Metabolic characterization of a Sirt5 deficient mouse model.Sirt5 缺陷型小鼠模型的代谢特征分析。
Sci Rep. 2013 Sep 30;3:2806. doi: 10.1038/srep02806.
7
Investigation of Carboxylic Acid Isosteres and Prodrugs for Inhibition of the Human SIRT5 Lysine Deacylase Enzyme.用于抑制人SIRT5赖氨酸脱酰酶的羧酸生物电子等排体和前药的研究。
Angew Chem Int Ed Engl. 2022 May 23;61(22):e202115805. doi: 10.1002/anie.202115805. Epub 2022 Mar 30.
8
Aryl Fluorosulfate Based Inhibitors That Covalently Target the SIRT5 Lysine Deacylase.基于芳基氟硫酸酯的抑制剂,共价靶向 SIRT5 赖氨酸脱酰酶。
Angew Chem Int Ed Engl. 2022 Nov 21;61(47):e202204565. doi: 10.1002/anie.202204565. Epub 2022 Oct 21.
9
The deacylase sirtuin 5 reduces malonylation in nonmitochondrial metabolic pathways in diabetic kidney disease.去酰化酶 Sirtuin 5 降低糖尿病肾病中非线粒体代谢途径中的丙二酰化。
J Biol Chem. 2023 Mar;299(3):102960. doi: 10.1016/j.jbc.2023.102960. Epub 2023 Feb 2.
10
Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer.药理学和基因干扰研究表明,SIRT5是乳腺癌一个有前景的治疗靶点。
Oncogene. 2021 Mar;40(9):1644-1658. doi: 10.1038/s41388-020-01637-w. Epub 2021 Jan 21.

本文引用的文献

1
Identification of 2-hydroxybenzoic acid derivatives as selective SIRT5 inhibitors.鉴定 2-羟基苯甲酸衍生物为选择性 SIRT5 抑制剂。
Eur J Med Chem. 2022 Nov 5;241:114623. doi: 10.1016/j.ejmech.2022.114623. Epub 2022 Jul 22.
2
Mitochondrial sirtuins genetic variations and gastric cancer risk: Evidence from retrospective observational study.线粒体沉默调节蛋白基因多态性与胃癌风险的关系:基于回顾性观察性研究的证据。
Gene. 2022 Jan 10;807:145951. doi: 10.1016/j.gene.2021.145951. Epub 2021 Sep 6.
3
Leigh Syndrome: A Tale of Two Genomes.Leigh综合征:两个基因组的故事
Front Physiol. 2021 Aug 11;12:693734. doi: 10.3389/fphys.2021.693734. eCollection 2021.
4
Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression.Sirt5 缺失导致的代谢重构促进 Kras 诱导的胰腺癌进展。
Gastroenterology. 2021 Nov;161(5):1584-1600. doi: 10.1053/j.gastro.2021.06.045. Epub 2021 Jul 8.
5
SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA.SIRT5 是急性髓系白血病的可靶向代谢脆弱性。
Blood Cancer Discov. 2021 May;2(3):266-287. doi: 10.1158/2643-3230.BCD-20-0168. Epub 2019 Dec 2.
6
The deacylase SIRT5 supports melanoma viability by influencing chromatin dynamics.去乙酰化酶 SIRT5 通过影响染色质动力学来支持黑色素瘤的生存能力。
J Clin Invest. 2021 Jun 15;131(12). doi: 10.1172/JCI138926.
7
Pharmacological and genetic perturbation establish SIRT5 as a promising target in breast cancer.药理学和基因干扰研究表明,SIRT5是乳腺癌一个有前景的治疗靶点。
Oncogene. 2021 Mar;40(9):1644-1658. doi: 10.1038/s41388-020-01637-w. Epub 2021 Jan 21.
8
Regulation of UCP1 and Mitochondrial Metabolism in Brown Adipose Tissue by Reversible Succinylation.UCP1 和棕色脂肪组织中线粒体代谢的可逆琥珀酰化调节。
Mol Cell. 2019 May 16;74(4):844-857.e7. doi: 10.1016/j.molcel.2019.03.021. Epub 2019 Apr 15.
9
Functional genetic variants in the SIRT5 gene promoter in acute myocardial infarction.SIRT5 基因启动子中的功能遗传变异与急性心肌梗死。
Gene. 2018 Oct 30;675:233-239. doi: 10.1016/j.gene.2018.07.010. Epub 2018 Jul 4.
10
Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology.SIRT5 去乙酰化酶在正常生理学和病理生物学中的功能。
Crit Rev Biochem Mol Biol. 2018 Jun;53(3):311-334. doi: 10.1080/10409238.2018.1458071. Epub 2018 Apr 11.